Emeritus Research is proud to report that we were the top recruiting site globally for AbbVie’s Risankizumab clinical trial for participants with Active Psoriatic Arthritis (PsA). 22 participants were successfully randomised over a 6 month recruitment period.
Emeritus Research has randomised 48 participants with PsA across 5 trials with 3 sponsors over the last 18 months. We have built a fantastic database of patients who are keen to participate in clinical trials. We look forward to working on upcoming trials for PsA and would be delighted to speak with sponsors and CROs.
Of course, we don’t just do rheumatology trials and would appreciate the opportunity to participate in feasibilities for all conditions outside of oncology.